CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) Dividend History

CASI Pharmaceuticals, Inc. is a biotechnology company focused on the development and commercialization of innovative treatments for cancer, infectious diseases, and other serious conditions. Founded in 2009 and headquartered in Rockville, Maryland, CASI aims to leverage its expertise in drug repurposing and development through strategic collaborations and regulatory approvals, primarily in China and other international markets. The company focuses on bringing both innovative and re-purposed therapies to underserved patient populations worldwide.

Website:

Dividend History

CASI Pharmaceuticals, Inc. Ordinary Shares currently does not pay dividends

Company News

  • CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

    CASI Pharmaceuticals (CASI) gets a proposal letter from its chairman for acquiring its business operations in China. Its shares rise on the news.

    Zacks Investment Research
    Featured Companies: ALXO ANVS CGEN
  • HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know

    HC Wainwright & Co. has decided to maintain its Buy rating of CASI Pharmaceuticals (NASDAQ:CASI) and raise its price target from $10.00 to $12.00. Shares of CASI Pharmaceuticals are trading up 1.33% over the last 24 hours, at $4.56 per share. A move to $12.00 would account for a 163.16% increase from the current share price. About CASI Pharmaceuticals CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. ...Full story available on Benzinga.com

    Benzinga
  • USANA Health Sciences (USNA) Q3 Earnings Miss Estimates

    USANA Health (USNA) delivered earnings and revenue surprises of -7.81% and 0.53%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: USNA
  • Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

    Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares rose 279.8% to $0.9115 in pre-market trading, after the company announced it plans to report new and updated data from the global randomized combination study of TPST-1120 in first-line hepatocellular carcinoma in a premarket press release on Oct. 11. Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) shares gained 211% to $2.77 in pre-market trading after falling 7% on Tuesday. Athersys, Inc. (NASDAQ: ATHX) shares rose 20.7% to $0.14 in pre-market trading, after falling 60% on Tuesday. Athersys said it intends to conduct additional data analysis with independent statisticians because the sample size in the Phase 3 MASTERS-2 is insufficiently powered to achieve the primary endpoint. Gaucho Group Holdings, Inc. (NASDAQ: VINO) shares climbed 42.7% to $1.27 in pre-market trading, after falling over 12% on Tuesday. Gaucho Group announced its journey towards organic cultivation for select sections of its renowned Pinot Noir and Cabernet Sauvignon vineyards. Connexa Sports Technologies Inc. (NASDAQ: CNXA) rose 34.7% to $2.56 in pre-market trading. AgileThought, Inc. (NASDAQ: AGIL) rose 27.7% to $0.1890 in pre-market trading. On Oct. 10, 2023, the Bankruptcy Court entered an order approving AgileThought Parties' and ...

    Benzinga
    Featured Companies: DVA ETWO HYLN MGRX PRZO SMX SPCB TPST WHLR
  • Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Surpass Estimates (Revised)

    Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 36.17% and 37.39%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: IONS
Dividend data last updated 06/08/2025 00:15:53 UTC